ENCORE Research Group, a division of Flourish Research, is a leading community-based clinical research network headquartered in Jacksonville, Florida. With more than 25 years of experience, ENCORE has conducted Phase I–IV trials across diverse therapeutic areas, completing over 2,700 studies and enrolling more than 130,000 participants. The organization is recognized for delivering consistent enrollment and high-quality clinical data through a network of multi-specialty investigators.

What sets ENCORE apart is its integrated, quality-focused approach to clinical research. In collaboration with its sister companies, MedEvidence and ClinAsyst, ENCORE extends its capabilities beyond traditional site operations. MedEvidence strengthens patient engagement through evidence-based medical communication and education, enhancing awareness, trust, and recruitment. ClinAsyst drives operational efficiency through technology-enabled solutions that streamline workflows, improve site performance, and support scalable growth.

Together, this ecosystem enables ENCORE to advance patient engagement, expand diversity in clinical trials, and improve operational execution. By combining deep site expertise with strategic innovation and collaboration, ENCORE continues to define a modern, patient-centric model for clinical research.